Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice.

Authors:
Lee G; Franklin J; Gupta K; Liu R; Zhou L and 8 more

Journal:
Blood Adv

Publication Year: 2023

DOI:
10.1182/bloodadvances.2022008094

PMCID:
PMC10698258

PMID:
37922427

Journal Information

Full Title: Blood Adv

Abbreviation: Blood Adv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest disclosure: D.N.W. has an ownership interest in CuronBiotech that is developing a pan-GSK3 inhibitor. The remaining authors declare no competing financial interests."

Evidence found in paper:

"Acknowledgments: This research was partially supported by the 10.13039/100008533Case Comprehensive Cancer Center Hematopoietic Cell Biorepository and Cellular Therapy Facility (NCI P30CA0437093)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025